{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:58:10Z","timestamp":1767610690205,"version":"3.38.0"},"reference-count":54,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.2169\/internalmedicine.3629-24","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T22:12:13Z","timestamp":1723241533000},"page":"871-879","source":"Crossref","is-referenced-by-count":1,"title":["Primary Aldosteronism and Hypokalemia-induced Rhabdomyolysis in a Patient with Aldosterone-producing Adenoma: A Case Report and Literature Review"],"prefix":"10.2169","volume":"64","author":[{"given":"Nobumasa","family":"Ohara","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshi","family":"Terajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsutaro","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tsubame Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Yoneoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Uonuma Kikan Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord 24: 651-659, 2014.","DOI":"10.1016\/j.nmd.2014.05.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis. Neurol 267: 877-882, 2020.","DOI":"10.1007\/s00415-019-09185-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 1889-1916, 2016.","DOI":"10.1210\/jc.2015-4061"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Naruse M, Katabami T, Shibata H, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J 69: 327-359, 2022.","DOI":"10.1507\/endocrj.EJ21-0508"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gruber S, Beuschlein F. Hypokalemia and the prevalence of primary aldosteronism. Horm Metab Res 52: 347-356, 2020.","DOI":"10.1055\/a-1134-4980"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dominic JA, Koch M, Guthrie GP Jr, Galla JH. Primary aldosteronism presenting as myoglobinuric acute renal failure. Arch Intern Med 138: 1433-1434, 1978.","DOI":"10.1001\/archinte.1978.03630340099036"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Schady W, Yuill GM. Myopathy and primary hyperaldosteronism. Neurology 31: 225-226, 1981.","DOI":"10.1212\/WNL.31.2.225-b"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ozg\u00fcr B, K\u00fcrsat S. Hypokalemic rhabdomyolysis aggravated by diuretics complicating Conn&apos;s syndrome without acute renal failure. Clin Nephrol 57: 89-91, 2002.","DOI":"10.5414\/CNP57089"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Petidis K, Douma S, Aslanidis S, Papaefthimiou P, Kartali N, Zamboulis C. Hypertension associated with rhabdomyolysis. J Clin Hypertens (Greenwich) 9: 60-62, 2007.","DOI":"10.1111\/j.1524-6175.2007.05811.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kotsaftis P, Savopoulos C, Agapakis D, et al. Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report. Cases J 2: 6813, 2009.","DOI":"10.4076\/1757-1626-2-6813"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tsai WT, Chen YL, Yang WS, Lin HD, Chien CC, Lin CL. Primary aldosteronism associated with severe hypokalemic rhabdomyolysis. Hormones (Athens) 11: 505-506, 2012.","DOI":"10.14310\/horm.2002.1385"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Finsterer J, L\u00e4sser S. Severe hypokalemic paralysis as a manifestation of a mitochondrial disorder. Tohoku J Exp Med 231: 9-12, 2013.","DOI":"10.1620\/tjem.231.9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Grifoni E, Fabbri A, Ciuti G, Matucci Cerinic M, Moggi Pignone A. Hypokalemia-induced rhabdomyolysis. Intern Emerg Med 9: 487-488, 2014.","DOI":"10.1007\/s11739-013-1033-8"},{"key":"14","unstructured":"14. Zavatto A, Concistr\u00e8 A, Marinelli C, et al. Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism. Eur Rev Med Pharmacol Sci 19: 3910-3916, 2015."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dyrmishi B, Olldashi T, Rista E, Fureraj T, Ylli D, Ylli A. Severe hypokalemia induced rhabdomyolysis by primary hyperaldosteronism coexistent with recurrent bilateral renal calculi. Acta Endocrinol (Buchar) 13: 228-231, 2017.","DOI":"10.4183\/aeb.2017.228"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Atsumi T, Ishikawa S, Miyatake T, Yoshida M. Myopathy and primary aldosteronism: electronmicroscopic study. Neurology 29: 1348-1353, 1979.","DOI":"10.1212\/WNL.29.10.1348"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mahdyoon H, Mermiges DN, Wisgerhof M. Conn&apos;s syndrome with rhabdomyolysis mimicking deep vein thrombophlebitis. South Med J 83: 346-347, 1990.","DOI":"10.1097\/00007611-199003000-00024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chow CP, Symonds CJ, Zochodne DW. Hyperglycemia, lumbar plexopathy and hypokalemic rhabdomyolysis complicating Conn&apos;s syndrome. Can J Neurol Sci 24: 67-69, 1997.","DOI":"10.1017\/S0317167100021132"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ka\u015fifo\u011flu T, Korkmaz C, Pa\u015fao\u011flu O. Conn&apos;s syndrome (primary hyperaldosteronism) simulating polymyositis. Rheumatol Int 25: 133-134, 2005.","DOI":"10.1007\/s00296-004-0462-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Goto A, Takahashi Y, Kishimoto M, et al. Primary aldosteronism associated with severe rhabdomyolysis due to profound hypokalemia. Intern Med 48: 219-223, 2009.","DOI":"10.2169\/internalmedicine.48.1444"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mart\u00ednez JJ, Oliveira CL, Meneses AL, et al. Rhabdomyolysis due to primary hyperaldosteronism. Endocrinol Nutr 56: 431-434, 2009.","DOI":"10.1016\/S1575-0922(09)72715-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Karag\u00fczel G, Bahat E, Imamo\u011flu M, Ahmeto\u011flu A, Yildiz K, Okten A. An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. J Pediatr Endocrinol Metab 22: 1087-1090, 2009.","DOI":"10.1515\/JPEM.2009.22.11.1087"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamashita S, Tsuchimochi W, Yonekawa T, et al. Myasthenia gravis complicated with primary aldosteronism and hypokalemic myopathy. Intern Med 48: 1465-1469, 2009.","DOI":"10.2169\/internalmedicine.48.2311"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tang YC, Wang SK, Yuan WL. Primary aldosteronism simulating polymyositis. J Rheumatol 38: 1529-1533, 2011.","DOI":"10.3899\/jrheum.110034"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wen Z, Chuanwei L, Chunyu Z, Hui H, Weimin L. Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: a case series. BMC Res Notes 6: 155, 2013.","DOI":"10.1186\/1756-0500-6-155"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Olt S, Yaylaci S, Tatli L, Gunduz Y, Garip T, Tamer A. Hypokalemia-induced myopathy and massive creatine kinase elevation as first manifestation of Conn&apos;s syndrome. Niger Med J 54: 283-284, 2013.","DOI":"10.4103\/0300-1652.119658"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cooray MS, Bulugahapitiya US, Peiris DN. Rhabdomyolysis: a rare presentation of aldosterone-producing adenoma. Indian J Endocrinol Metab 17: S237-S239, 2013.","DOI":"10.4103\/2230-8210.119583"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lee JH, Kim E, Chon S. Hypokalemia-induced rhabdomyolysis by primary aldosteronism coexistent with sporadic inclusion body myositis. Ann Rehabil Med 39: 826-832, 2015.","DOI":"10.5535\/arm.2015.39.5.826"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wu C, Xin J, Xin M, et al. Hypokalemic myopathy in primary aldosteronism: a case report. Exp Ther Med 12: 4064-4066, 2016.","DOI":"10.3892\/etm.2016.3864"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pecnik P, M\u00fcller P, Vrabel S, Windpessl M. Two cases of hypokalaemic rhabdomyolysis: same but different. BMJ Case Rep 2018: bcr2017223609, 2018.","DOI":"10.1136\/bcr-2017-223609"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kollipara S, Ravindra S, Pai K, Shetty S. Quadriplegia and rhabdomyolysis as a presenting feature of Conn&apos;s syndrome. BMJ Case Rep 14: e234686, 2021.","DOI":"10.1136\/bcr-2020-234686"},{"key":"32","unstructured":"32. Maung AC, Kerwen AK, Ching LP. Hypokalaemic rhabdomyolysis as initial presentation of primary aldosteronism. J R Coll Physicians Edinb 5: 149-152, 2021."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Chen CT, Wang YC, Lin CM. Hypokalemia-induced rhabdomyolysis caused by adrenal tumor-related primary aldosteronism: a report of 2 cases. Am J Case Rep 22: e929758, 2021.","DOI":"10.12659\/AJCR.929758"},{"key":"34","unstructured":"34. Sirkeci O, Sirkeci EE, Kucukciloglu Y. Severe hypokalemia and rhabdomyolysis caused by Conn syndrome. Clin Ter 172: 407-409, 2021."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Han R, Jiang X. Hypokalemia-induced rhabdomyolysis as the first symptom of primary aldosteronism: a case report and literature review. Ann Palliat Med 11: 2778-2784, 2022.","DOI":"10.21037\/apm-21-3010"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. D\u00edaz-L\u00f3pez EJ, Villar-Taibo R, Rodriguez-Carnero G, et al. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review. Front Endocrinol (Lausanne) 14: 1257078, 2023.","DOI":"10.3389\/fendo.2023.1257078"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Nishikawa T, Omura M, Satoh F, et al.; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism - the Japan Endocrine Society 2009. Endocr J 58: 711-21, 2011.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 42: 1235-1481, 2019.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lau SK, Weiss LM. The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40: 757-768, 2009.","DOI":"10.1016\/j.humpath.2009.03.010"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Rege J, Turcu AF, Else T, Auchus RJ, Rainey WE. Steroid biomarkers in human adrenal disease. J Steroid Biochem Mol Biol 190: 273-280, 2019.","DOI":"10.1016\/j.jsbmb.2019.01.018"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Sakuma I, Suematsu S, Matsuzawa Y, et al. Characterization of steroidogenic enzyme expression in aldosterone-producing adenoma: a comparison with various human adrenal tumors. Endocr J 60: 329-336, 2013.","DOI":"10.1507\/endocrj.EJ12-0270"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Monticone S, Castellano I, Versace K, et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol 411: 146-154, 2015.","DOI":"10.1016\/j.mce.2015.04.022"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol 33: 155-196, 2022.","DOI":"10.1007\/s12022-022-09710-8"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol 7: 75-84, 2011.","DOI":"10.1038\/nrneph.2010.175"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69: 1811-1820, 2017.","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Umakoshi H, Sakamoto R, Matsuda Y, et al. Role of aldosterone and potassium levels in sparing confirmatory tests in primary aldosteronism. J Clin Endocrinol Metab 105: dgz148, 2020.","DOI":"10.1210\/clinem\/dgz148"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Lenzini L, Rossitto G, Maiolino G, Letizia C, Funder JW, Rossi GP. A meta-analysis of somatic KCNJ5 K<sup>+<\/sup> channel mutations in 1636 patients with an aldosterone-producing adenoma. J Clin Endocrinol Metab 100: E1089-E1095, 2015.","DOI":"10.1210\/jc.2015-2149"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of <i>KCNJ5<\/i> mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab 97: E1567-E1572, 2012.","DOI":"10.1210\/jc.2011-3132"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Okamura T, Nakajima Y, Katano-Toki A, et al. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations. Endocr J 64: 39-47, 2017.","DOI":"10.1507\/endocrj.EJ16-0243"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol 5: 725-731, 1993.","DOI":"10.1097\/00002281-199305060-00006"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Allison RC, Bedsole DL. The other medical causes of rhabdomyolysis. Am J Med Sci 326: 79-88, 2003.","DOI":"10.1097\/00000441-200308000-00005"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol 33: 265-276, 2013.","DOI":"10.1016\/j.semnephrol.2013.04.007"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol 26: 1781-1788, 2011.","DOI":"10.1007\/s00467-010-1727-3"},{"key":"54","unstructured":"54. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 67: 272-283, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_3629-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:31:15Z","timestamp":1742009475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_3629-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3629-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"article-number":"3629-24"}}